lcSSc
…ine in lcSSc. In addition, a trial of tofacitinib with 40 (61%) lcSSc patients showed that this drug was more effective than low-dose…
4articles mentioning diseases
5disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: Limited cutaneous systemic sclerosis ×
Limited cutaneous systemic sclerosis
This disease is selected. Its supporting articles are shown below.
Articles mentioning Limited cutaneous systemic sclerosis
4 articles · page 1 of 1sine sclerodermalcSScLimited cutaneous Systemic sclerosisCONQUERantiTOPOenteral/parenteral nutrition
…f patients with early SSc, 5% and 11% of patients with lcSSc or sine scleroderma experienced disease progression at 12 and 24 months, respective…
sine sclerodermalcSScSScLimited cutaneous systemic sclerosis
…he EUSTAR database. Patients were included if they had lcSSc or sine scleroderma, fulfilled the 2013 ACR/EULAR classification criteria, and had …
lcSScinterstitial lung diseasediffuse cutaneous systemic sclerosismyositismyocarditisarthritisSSclimited cutaneous systemic sclerosismycophenolate mofetil
…%). Interestingly, a majority of respondents would likely treat lcSSc in the presence of subclinical organ involvement, including sub…